CYP19A1 and leiomyoma: EA exhibited a time- and dose-dependent inhibition of intracellular aromatase activity in leiomyoma cells, which potently inhibit the capability of the tumor cell in self-supplying estrogen, the hormone that results in the proliferation of leiomyoma cells (Lee et al., 2004b).